Please login to the form below

Not currently logged in
Email:
Password:

Par elects new chairman

US generic drug manufacturer Par Pharmaceutical has elected president and CEO Patrick G LePore as chairman of the board of directors.

US generic drug manufacturer Par Pharmaceutical has elected president and CEO Patrick G LePore as chairman of the board of directors.

LePore, who joined Par's board in May 2006, has been president and CEO since September 2006.

LePore replaces John D Abernathy as chairman. Abernathy will remain a board member.

Joseph E Smith, a member of the board since 2004, has been named lead director. Prior to his retirement in 1997, he held leadership positions with Warner-Lambert.

On 9 August, Par's shares fell USD 0.73, or 3.5 per cent, to USD 20.03 in pm trading. Shares have traded between USD 15.50 and USD 30.68 over the past year.

10th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
...
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics